Kintzel Polly E, Zhao Ting, Wen Bo, Sun Duxin
Polly E. Kintzel, Pharm.D., BCPS, BCOP, is Clinical Lead for Adult Blood/Bone Marrow Transplantation and Adult Oncology, Pharmacy Department, Spectrum Health, Grand Rapids, MI. Ting Zhao, Ph.D., is Research Associate; Bo Wen, Ph.D., is Research Fellow; and Duxin Sun, Ph.D., is Professor, Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI.
Am J Health Syst Pharm. 2014 Dec 1;71(23):2061-5. doi: 10.2146/ajhp130697.
The chemical stability of a sterile admixture containing metoclopramide 1.6 mg/mL, diphenhydramine hydrochloride 2 mg/mL, and dexamethasone sodium phosphate 0.16 mg/mL in 0.9% sodium chloride injection was evaluated.
Triplicate samples were prepared and stored at room temperature without light protection for a total of 48 hours. Aliquots from each sample were tested for chemical stability immediately after preparation and at 1, 4, 8, 24, and 48 hours using liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. Metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate were selectively monitored using multiple-reaction monitoring. Samples were diluted differently for quantitation using three individual LC-MS/MS methods. To determine the drug concentration of the three compounds in the samples, three calibration curves were constructed by plotting the peak area or the peak area ratio versus the concentration of the calibration standards of each tested compound. Apixaban was used as an internal standard. Linearity of the calibration curve was evaluated by the correlation coefficient r(2).
Constituents of the admixture of metoclopramide 1.6 mg/mL, diphenhydramine hydrochloride 2 mg/mL, and dexamethasone sodium phosphate 0.16 mg/mL in 0.9% sodium chloride injection retained more than 90% of their initial concentrations over 48 hours of storage at room temperature without protection from light. The observed variability in concentrations of these three compounds was within the limits of assay variability.
An i.v. admixture containing metoclopramide 1.6 mg/mL, diphenhydramine hydrochloride 2 mg/mL, and dexamethasone sodium phosphate 0.16 mg/mL in 0.9% sodium chloride injection was chemically stable for 48 hours when stored at room temperature without light protection.
评估含1.6 mg/mL甲氧氯普胺、2 mg/mL盐酸苯海拉明和0.16 mg/mL地塞米松磷酸钠的无菌混合液在0.9%氯化钠注射液中的化学稳定性。
制备一式三份的样品,在无光照保护的室温下储存48小时。使用液相色谱-串联质谱(LC-MS/MS)分析法,在制备后以及1、4、8、24和48小时对每个样品的等分试样进行化学稳定性测试。使用多反应监测选择性监测甲氧氯普胺、盐酸苯海拉明和地塞米松磷酸钠。使用三种单独的LC-MS/MS方法对样品进行不同程度的稀释以进行定量。为了测定样品中这三种化合物的药物浓度,通过绘制峰面积或峰面积比与每种测试化合物校准标准品浓度的关系图,构建了三条校准曲线。阿哌沙班用作内标。通过相关系数r(2)评估校准曲线的线性。
含1.6 mg/mL甲氧氯普胺、2 mg/mL盐酸苯海拉明和0.16 mg/mL地塞米松磷酸钠的0.9%氯化钠注射液混合液的成分,在无光照保护的室温下储存48小时后,其初始浓度保留率超过90%。这三种化合物观察到的浓度变异性在分析变异性范围内。
含1.6 mg/mL甲氧氯普胺、2 mg/mL盐酸苯海拉明和0.16 mg/mL地塞米松磷酸钠的0.9%氯化钠注射液静脉混合液,在无光照保护的室温下储存时,化学稳定性为48小时。